News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Targeted Genetics Corporation Gene Therapy Fails to Treat Arthritis
May 30, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 30 (Reuters) - Targeted Genetics Corp's troubled gene therapy product, tgAAC94, was not effective in treating inflammatory arthritis in an early trial.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
MORE ON THIS TOPIC
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 26, 2026
·
1 min read
·
Gabrielle Masson
FDA
Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed
August 26, 2026
·
2 min read
·
Jef Akst
Job Trends
CDMO hiring tough as demand for specialized talent outpaces supply
August 26, 2026
·
5 min read
·
Angela Gabriel
Immunology and inflammation
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
August 25, 2026
·
1 min read
·
Tristan Manalac
